{
    "clinical_study": {
        "@rank": "85583", 
        "arm_group": {
            "arm_group_label": "Meal composition", 
            "arm_group_type": "Other", 
            "description": "Changing the glycaemic index of the meals consumed after exercise and before sleep. (High GI - High GI, Low GI - Low GI, High GI - Low GI, Low GI - High GI)."
        }, 
        "brief_summary": {
            "textblock": "The investigators hypothesise that manipulating the glycaemic index of the meal after\n      exercise and before sleep will help prevent Type 1 diabetes individuals experiencing\n      hypoglycaemia."
        }, 
        "brief_title": "Guidelines for Post-exercise Dietary Intake in T1DM", 
        "completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "condition": "Type 1 Diabetes Mellitus", 
        "condition_browse": {
            "mesh_term": [
                "Diabetes Mellitus", 
                "Diabetes Mellitus, Type 1"
            ]
        }, 
        "eligibility": {
            "criteria": {
                "textblock": "Inclusion Criteria:\n\n          -  Aged between 18-50 years old (male or female).\n\n          -  Free from any diabetes related complications (apart from mild background diabetic\n             retinopathy).\n\n          -  HbA1c <8.5%.\n\n          -  Not taking any prescribed medication other than insulin, and treated with a stable\n             insulin regimen composed of a combination of slow/long acting insulin (glargine or\n             detemir) and fast-acting insulin analogues (lispro or aspart), for a minimum of 6\n             months before the start of the study.\n\n          -  Demonstrate normal cardiac function in response to exercise.\n\n        Exclusion Criteria:\n\n          -  Aged younger than 18, or older than 50 years.\n\n          -  Suffering from, or diagnosed with a diabetes related complication (apart from mild\n             background diabetic retinopathy).\n\n          -  HbA1c >8.5%.\n\n          -  Currently taking prescribed medication, and not currently treated with a stable basal\n             bolus regimen composed of a combination glargine or determir, and lispro or aspart\n             for at least 6 months before the start of the study.\n\n          -  Failure to demonstrate normal cardiopulmonary responses during exercise, or have a\n             medical condition which could prevent completion of exercise or be exacerbated\n             because of."
            }, 
            "gender": "Both", 
            "healthy_volunteers": "No", 
            "maximum_age": "50 Years", 
            "minimum_age": "18 Years"
        }, 
        "enrollment": {
            "#text": "10", 
            "@type": "Actual"
        }, 
        "firstreceived_date": "February 15, 2013", 
        "has_expanded_access": "No", 
        "id_info": {
            "nct_id": "NCT01794650", 
            "org_study_id": "West-Walker2"
        }, 
        "intervention": {
            "arm_group_label": "Meal composition", 
            "intervention_name": "Meal composition", 
            "intervention_type": "Dietary Supplement"
        }, 
        "is_fda_regulated": "No", 
        "keyword": "T1DM, Exercise, Hypoglycaemia", 
        "lastchanged_date": "November 14, 2013", 
        "location": {
            "facility": {
                "address": {
                    "city": "Newcastle upon Tyne", 
                    "country": "United Kingdom", 
                    "state": "Tyne and Wear", 
                    "zip": "NE10 9PY"
                }, 
                "name": "Clinical Research Facility, Royal Victoria Infirmary"
            }
        }, 
        "location_countries": {
            "country": "United Kingdom"
        }, 
        "number_of_arms": "1", 
        "official_title": "The Metabolic and Glycaemic Responses to Changes in the Glycaemic Index of the Meal Consumed After Performing Evening Exercise in Type 1 Diabetes Mellitus", 
        "overall_official": {
            "affiliation": "Northumbria University", 
            "last_name": "Daniel J West, PhD, BSc", 
            "role": "Principal Investigator"
        }, 
        "overall_status": "Completed", 
        "oversight_info": {
            "authority": "United Kingdom: National Health Service", 
            "has_dmc": "Yes"
        }, 
        "phase": "N/A", 
        "primary_completion_date": {
            "#text": "November 2013", 
            "@type": "Actual"
        }, 
        "primary_outcome": {
            "description": "24 hour, post-exercise, glucose area under the curve.", 
            "measure": "24 hour blood glucose area under the curve", 
            "safety_issue": "No", 
            "time_frame": "24 hours"
        }, 
        "required_header": {
            "download_date": "ClinicalTrials.gov processed this data on June 04, 2014", 
            "link_text": "Link to the current ClinicalTrials.gov record.", 
            "url": "http://clinicaltrials.gov/show/NCT01794650"
        }, 
        "responsible_party": {
            "responsible_party_type": "Sponsor"
        }, 
        "secondary_outcome": {
            "description": "Blood beta-hydroxybutyrate concentrations", 
            "measure": "Ketogenesis", 
            "safety_issue": "No", 
            "time_frame": "60 minutes before and 24 hours post-exercise"
        }, 
        "source": "Northumbria University", 
        "sponsors": {
            "lead_sponsor": {
                "agency": "Northumbria University", 
                "agency_class": "Other"
            }
        }, 
        "start_date": "March 2013", 
        "study_design": "Intervention Model: Single Group Assignment, Masking: Open Label, Primary Purpose: Basic Science", 
        "study_type": "Interventional", 
        "verification_date": "November 2013"
    }
}